Unraveling the interaction between doxorubicin and DNA origami nanostructures for customizable chemotherapeutic drug release

Doxorubicin (DOX) is a common drug in cancer chemotherapy, and its high DNA-binding affinity can be harnessed in preparing DOX-loaded DNA nanostructures for targeted delivery and therapeutics. Although DOX has been widely studied, the existing literature of DOX-loaded DNA-carriers remains limited an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ijäs, Heini, Shen, Boxuan, Heuer-Jungemann, Amelie, Keller, Adrian, Kostiainen, Mauri A, Liedl, Tim, Ihalainen, Janne A, Linko, Veikko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Chemical Biology and Nucleic Acid Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034656/
https://www.ncbi.nlm.nih.gov/pubmed/33660776
http://dx.doi.org/10.1093/nar/gkab097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034656/
https://www.ncbi.nlm.nih.gov/pubmed/33660776
http://dx.doi.org/10.1093/nar/gkab097

Ejemplares similares